Anger at Australian radio station over royal hoax












LONDON (AP) — It started out as a joke, but ended in tragedy.


The sudden death of a nurse who unwittingly accepted a prank call to a London hospital about Prince William‘s pregnant wife Kate has shocked Britain and Australia, and sparked an angry backlash Saturday from some who argue the DJs who carried out the hoax should be held responsible.












At first, the call by two irreverent Australian DJs posing as royals was picked up by news outlets around the world as an amusing anecdote about the royal pregnancy. Some complained about the invasion of privacy, the hospital was embarrassed, and the radio presenters sheepishly apologized.


But the prank took a dark twist Friday with the death of nurse Jacintha Saldanha, a 46-year-old mother of two, three days after she took the hoax call. Police have not yet determined Saldanha‘s cause of death, but people from London to Sydney have been making the assumption that she died because of stress from the call.


King Edward VII’s Hospital, where the former Kate Middleton was being treated for acute morning sickness this week, wrote a strongly-worded letter to the 2DayFM radio station’s parent company Southern Cross Austereo, condemning the “truly appalling” hoax and urging it to take steps to ensure such an incident would never happen again.


“The immediate consequence of these premeditated and ill-considered actions was the humiliation of two dedicated and caring nurses who were simply doing their job tending to their patients,” the letter read. “The longer term consequence has been reported around the world and is, frankly, tragic beyond words.”


The hospital did not comment when asked whether it believed the prank call had directly caused Saldanha’s death, only saying that the protest letter spoke for itself.


DJs Mel Grieg and Michael Christian, who apologized for the prank on Tuesday, took down their Twitter accounts after they were bombarded by thousands of abusive comments. Rhys Holleran, CEO of Southern Cross Austereo, said the pair have been offered counseling and were taken off the air indefinitely.


No one could have foreseen the tragic consequences of the prank, he stressed.


“I spoke to both presenters early this morning and it’s fair to say they’re completely shattered,” Holleran told reporters on Saturday.


“These people aren’t machines, they’re human beings,” he said. “We’re all affected by this.”


Details about Saldanha have been trickling out since the duty nurse’s body was found at apartments provided by the private hospital, which has treated a line of royals before, including Prince Philip, who was hospitalized there for a bladder infection in June.


The nurse, who was originally from India, had lived with her partner Benedict Barboza and a teenage son and daughter in Bristol, in southwestern England, for the past nine years. The hospital praised her as a “first-class nurse” who was well-respected and popular among colleagues during her four years working there.


Just before dawn on Tuesday, Saldanha was looking after her patients when the phone rang. A woman pretending to be Queen Elizabeth II asked to speak to the duchess, and, believing the caller, Saldanha transferred the call to a fellow nurse caring for the duchess, who spoke to the two DJs about Kate’s condition live on air.


During the call — which was put online and later broadcast on news channels worldwide — Grieg mimicked the Britain’s monarch’s voice and asked about the duchess’ health. She was told Kate “hasn’t had any retching with me and she’s been sleeping on and off.” Grieg and Christian, who pretended to be Prince Charles, also discussed with the nurse when they could travel to the hospital to check in on Kate.


Three days later, officers responding to reports that a woman was found unconscious discovered Saldanha, who was pronounced dead at the scene. Police didn’t release a cause of death, but said they didn’t find anything suspicious. A coroner will make a determination on the cause.


In the aftermath of Saldanha’s death, some speculated about whether the nurse was subject to pressure to resign or about to be punished for the mistake. Royal officials said Prince William and Kate were “deeply saddened,” but insisted that the palace had not complained about the hoax. King Edward VII’s Hospital also maintained that it did not reprimand Saldanha.


“We did not discipline the nurse in question. There were no plans to discipline her,” a hospital spokesman said. He declined to provide further details, and did not respond to questions about the second nurse’s condition.


The Australian Communications and Media Authority, which regulates radio broadcasting, said it has received complaints about the prank and is discussing the matter with the Sydney-based station, which yanked its Facebook page after it received thousands of angry comments.


Holleran, the radio executive, would not say who came up with the idea for the call. He only said that “these things are often done collaboratively.” He said 2DayFM would work with authorities, but was confident the station hadn’t broken any laws, noting that prank calls in radio have been happening “for decades.”


The station has a history of controversy, including a series of “Heartless Hotline” shows in which disadvantage people were offered a prize that could be taken away from them by listeners.


Saldanha’s family asked for privacy in a brief statement issued through London police.


Flowers were left outside the hospital’s nurse’s apartments, with one note reading: “Dear Jacintha, our thoughts are with you and your family. From all your fellow nurses, we bless your soul. God bless.”


Officials from St. James’s Palace have said the duchess is not yet 12 weeks pregnant. The child would be the first for her and William.


Europe News Headlines – Yahoo! News


Read More..

Rolling Stones hit NY for 50th anniversary gig












NEW YORK (AP) — “Time Waits for No One,” the Rolling Stones sang in 1974, but lately it’s seemed like that grizzled quartet does indeed have some sort of exemption from the ravages of time.


At an average age of 68-plus years, the British rockers are clearly in fighting form, sounding tight, focused and truly ready for the spotlight at a rapturously received pair of London concerts last month.












On Saturday, Mick Jagger, Keith Richards, Ronnie Wood and Charlie Watts hit New York for the first of three U.S. shows on their “50 and Counting” mini-tour, marking a mind-boggling half-century since the band first began playing its unique brand of blues-tinged rock.


And the three shows — Saturday’s at the new Barclays Center in Brooklyn, then two in Newark, N.J., on Dec. 13 and 15 — aren’t the only big dates on the agenda. Next week the Stones join a veritable who’s who of British rock royalty and U.S. superstars at the blockbuster 12-12-12 Sandy benefit concert at Madison Square Garden. Also scheduled to perform: Paul McCartney, the Who, Eric Clapton, Bruce Springsteen & The E Street Band, Alicia Keys, Kanye West, Eddie Vedder, Billy Joel, Roger Waters and Chris Martin.


The Stones‘ three U.S. shows promise to have their own special guests, too. Mary J. Blige will be at the Brooklyn gig, as well as guitarist Gary Clark Jr., the band has announced. (Blige performed a searing “Gimme Shelter” with frontman Jagger in London.) Rumors are swirling of huge names at the Dec. 15 show, which also will be on pay-per-view.


In a flurry of anniversary activity, the band also released a hits compilation last month with two new songs, “Doom and Gloom” and “One More Shot,” and HBO premiered a new documentary on their formative years, “Crossfire Hurricane.”


The Stones formed in London in 1962 to play Chicago blues, led at the time by the late Brian Jones and pianist Ian Stewart, along with Jagger and Richards, who’d met on a train platform a year earlier. Bassist Bill Wyman and drummer Charlie Watts were quick additions.


Wyman, who left the band in 1992, was a guest at the London shows last month, as was Mick Taylor, the celebrated former Stones guitarist who left in 1974 — to be replaced by Wood, the newest Stone and the youngster at 65.


The inevitable questions have been swirling about the next step for the Stones: another huge global tour, on the scale of their last one, “A Bigger Bang,” which earned more than $ 550 million between 2005 and 2007? Something a bit smaller? Or is this mini-tour, in the words of their new song, really “One Last Shot”?


The Stones won’t say. But in an interview last month, they made clear they felt the 50th anniversary was something to be marked.


“I thought it would be kind of churlish not to do something,” Jagger told The Associated Press. “Otherwise, the BBC would have done a rather dull film about the Rolling Stones.”


__


Associated Press writer David Bauder contributed to this report.


Entertainment News Headlines – Yahoo! News


Read More..

Pfizer/Bristol drug cuts recurrence of blood clots – study












(Reuters) – A new blood clot preventer from Pfizer Inc and Bristol-Myers Squibb Co reduced the risk of recurrence of clots in veins and lungs and death by 80 percent with no increase in major bleeding in a study testing extended use of the drug.


In the year-long trial of 2,486 patients who had been previously treated for the condition known as venous thromboembolism (VTE) the drug, apixaban, met the combined primary goal by significantly reducing the recurrence of blood clots and death from any cause compared with a placebo, according to data presented at the American Society of Hematology (ASH) meeting in Atlanta, Georgia.












The rate of recurrence or death was 11.6 percent in the placebo group compared with 3.8 percent for those who got 2.5 milligrams of apixaban and 4.2 percent for the 5 mg dose of the drug. The results were also published in the New England Journal of Medicine.


The incidence of major bleeding, always a concern with blood thinners, was extremely low in all three arms of the trial, researchers said – 0.5 percent for placebo, 0.2 percent for the low dose of apixaban and 0.1 percent for the higher dose.


“Usually when you have an effective antithrombotic you have to pay a price in terms of bleeding. This was not the case in this study,” Dr. Giancarlo Agnelli, the study’s principal investigator, said in a telephone interview.


“There was no evidence at all of increased major bleeding and this is extremely important because you are comparing an active drug with placebo,” he said.


There was a slightly higher rate of clinically relevant nonmajor bleeding, such as nose bleeds that required medical attention, observed in patients taking the higher dose of apixaban at 4.2 percent compared with the low dose and placebo, researchers said.


Apixaban belongs to a new class of blood thinners that aim to replace decades old and difficult to use warfarin. The drug, which will be sold under the brand name Eliquis, is widely considered to be one of the most important new medicines for Pfizer and Bristol-Myers, both of which saw their top selling products lose patent protection in the past year.


AWAITING U.S. APPROVAL


It is approved in Europe and awaiting a U.S. approval decision for preventing blood clots and strokes in patients with atrial fibrillation – a type of irregular heart beat – and is also being tested against warfarin as a primary treatment for VTE with data expected next year.


A rival drug from Bayer and Johnson & Johnson called Xarelto is already approved for both conditions, but based on clinical data analysts have said they believe Eliquis is the best class.


An approval for extended use in VTE patients, during which they would take the drug for at least a year after initial treatment, could significantly boost future sales.


“The evidence is for one year. The next step would be to see whether this clinical benefit is extended after one year,” Agnelli said.


VTE consists of deep vein thrombosis, typically blood clots in the legs, and pulmonary embolism, which are dangerous clots in the lungs. Clots that begin in the extremities can travel to the heart and lungs and can be fatal. VTE is typically treated with warfarin for three to six months.


After that, “there is quite a remarkable level of uncertainty about whether to extend or not,” explained Agnelli, professor of internal medicine at the University of Perugia in Italy, who presented the data at the ASH meeting.


“Extended treatment might be clinically relevant because the recurrence rate after stopping treatment can be 10 percent in the first year,” Agnelli said. “Reducing the recurrence of VTE means reduced hospitalization costs and in some cases fewer fatal events.”


Physicians have been looking for alternatives to warfarin, which must be closely monitored to keep levels therapeutic but not toxic. The new drugs do not require monitoring or the dietary and lifestyle changes necessary with warfarin. But they still face an uphill battle as warfarin is far less expensive, and doctors have a comfort level using a drug that has been around for more than half a century despite the challenges.


Patients in the study had received treatment with warfarin for six to 12 months before starting the one-year extension trial that aimed to show further treatment could reduce recurrence rates and to see if the lower dose of apixaban was a viable option.


“It is quite clear that the lower dose is as effective as the higher. For the first time we showed that by reducing the dose of an antithrombotic agent in this clinical setting we can have the same efficacy with no major bleeding,” Agnelli said.


“This is actually something that could change clinical practice,” he added.


(Reporting by Bill Berkrot; Editing by Jilian Mincer, Berard Orr)


Health News Headlines – Yahoo! News


Read More..

Investors offer about $38.8 billion euros in Greek debt buyback: source












ATHENS (Reuters) – Greece is set to purchase back about half of its debt owned by private investors, broadly succeeding in a bond buyback that is key to the country’s international bailout, a Greek government official said on Saturday.


Greek and foreign bondholders offered the targeted 30 billion euros ($ 38.8 billion) in the deal, which is central to efforts by Greece’s euro zone and International Monetary Fund lenders to cut its debt to manageable levels.












“The buyback went well in broad terms. The amount offered by investors was within the range expected, about 30 billion euros,” the official told Reuters on condition of anonymity. He did not provide more details.


No formal announcement is expected before Monday, another official told Reuters.


The buyback accounts for about half of a broader, 40-billion euro EU/IMF debt relief package for Athens agreed in November. The package broadly doubles the average maturity of its rescue loans to almost 30 years and cuts its interest rates by one percentage point to a level far below 1 percent.


Under its terms, Athens will spend up to 10 billion euros of borrowed money to buy back bonds with a nominal value of about 30 billion euros. This is nearly half the 63 billion euros of Greek debt held by private investors eligible for the plan.


Since the bonds are to be bought far below their nominal value, the country’s net debt burden would fall by about 20 billion euros.


A successful buyback will ensure that the IMF, which contributes about a third of Greece’s bailout loans, will stay on board of the rescue. It would also unlock the payment of 34.4 billion euros of aid later this month.


Athens badly needs that money to refloat its ailing economy by replenishing the capital of its cash-strapped banks and settle arrears with government suppliers.


The EU and the IMF have been withholding rescue payments to Greece for six months because it had fallen short of promises to shore up its finances, privatize and make its economy more competitive.


Athens has received 148.6 billion euros in EU/IMF funds since May 2010. It stands to get almost 90 billion euros more by the end of 2014.


But the rescue comes at a heavy price. Austerity measures taken in exchange for aid have plunged the country into economic depression. Unemployment hit a record 26 percent in September, the highest in the euro zone.


The economy is going through its fifth consecutive year of recession and is expected to have shrunk by 24 percent when recovery begins in 2014.


GREEK BANKS ON BOARD


The buyback was expected to go well after Greek banks, which hold about 17 billion euros of bonds, announced shortly before a Friday deadline they would take part. Two Cypriot lenders also said they would offer their bonds.


Foreign investors have offered between 15 and 16 billion euros worth of bonds, Greek newspapers reported on Saturday, citing initial estimates without saying how they got them.


Athens’ hopes of drawing enough investors to the scheme grew after it announced better-than-expected terms on Monday, with price ranges at a premium over market prices.


The price range varied from a minimum of 30.2 to 38.1 percent and a maximum of 32.2 to 40.1 percent of the principal amount, depending on the maturities of the 20 series of outstanding bonds.


Hedge funds, which bought the debt at rock-bottom prices when it was feared the country would exit the euro, are estimated to hold a large part of Greek debt and the offer was seen as good enough to make them a nice profit.


“Athens put forth a reasonable if not generous offer for hedge funds to participate,” Sassan Ghahramani, CEO at New York-based Macro Advisers, a hedge fund consultancy, said on Friday.


“I expect there will be strong participation from hedge funds, tendering a substantial portion of their Greek bond holdings,” he said.


The government also enticed Greek bankers by offering to protect them from possible shareholder lawsuits stemming from the buyback.


Greek bankers had been reluctant to take part, in the fear they would book losses on top of the ones they incurred earlier this year when Athens enforced a debt cut on its bondholders.


But the lenders were nevertheless expected to participate because they depend on the bailout funds that Athens stands to receive if its bailout continues smoothly.


($ 1 = 0.7735 euros)


(Writing by Harry Papachristou; editing by James Jukwey)


Business News Headlines – Yahoo! News


Read More..

‘Post-PC’ is more than just marketing buzz for Apple CEO Tim Cook












Apple (AAPL) is no stranger to ditching technologies when it deems them to no longer be useful. The company dropped the floppy disk for a CD-ROM drive on the first iMac and most recently has shifted to building MacBooks and iMacs without any physical disc drives. In his first televised interview on NBC’s Rockcenter with Brian Williams, Apple CEO Tim Cook revealed that he has “ditched physical keyboards” now that he spends 80% of his time using his iPad “authoring email” and “working on things.” Cook says he’s gotten quite good at typing on the screen and advises people to trust auto-correction as it’s “quite good” — though it’s a feature we still blast iOS for some five years after the first iPhone launched. But what does it mean when the boss of the country’s most valuable company and the most revered technology company in the world doesn’t even use physical keyboards anymore? Perhaps the “post-PC” era will become mainstream sooner than we thought.


For years, Apple has touted the idea that we’re entering the “post-PC” era – a period when touchscreen-equipped smartphones and tablets will eclipse desktops, notebooks and complex operating systems as they slowly fade away into a niche reserved for professionals.












While there will still be a need for notebooks, Windows PCs and Macs, the increasing numbers of smartphones and tablets sold and continued decline of worldwide PC sales support Apple’s claim that mobile is where the next tech battleground is, even if Microsoft (MSFT) thinks otherwise.


The term “dogfooding” is often thrown around between tech blogs and Cook is doing exactly that — using his “own product to demonstrate the quality and capabilities of the product.”


As Steve Jobs once said, Apple only builds products its own engineers and designers would use themselves.


Cook’s not saying, “iPads are great” for some people and some tasks. The fact that Cook uses his iPad for 80% of his work and an iPhone all the time suggests he and Apple are serious about this post-PC era. Apple wants iPads and iPhones to be great for all of your computing needs.


Apple is serious enough about it that the big boss has shifted his habits from old-school typing on actual keyboards to using virtual keyboards. And for all we know, Cook could be using even more natural human interfaces such as more voice recognition (ex: Siri in iOS and built-in dictation in OS X Mountain Lion).


Will physical keyboards go the way of the dodo in the next handful of years? It’s doubtful, but don’t be surprised if you see fewer and fewer offices with QWERTY keyboards attached to PCs and more desks and execs just carrying tablets and a smartphone on the side.


Get more from BGR.com: Follow us on Twitter, Facebook


Gadgets News Headlines – Yahoo! News


Read More..

UK’s Kate and William “saddened” by nurse’s death












LONDON (Reuters) – Britain’s Prince William and his wife Kate said on Friday they were “deeply saddened” by the death of a nurse who fell victim to a prank call from an Australian radio station seeking details of the duchess’s condition while she was in hospital for morning sickness.


The King Edward VII hospital earlier confirmed the death of the nurse, Jacinda Saldanha.












“Their Royal Highnesses were looked after so wonderfully well at all times by everybody at King Edward VII Hospital, and their thoughts and prayers are with Jacintha Saldanha‘s family, friends and colleagues at this very sad time,” said a statement from William’s office.


(Reporting by Tim Castle; editing by Stephen Addison)


Celebrity News Headlines – Yahoo! News


Read More..

GlaxoSmithKline in deal with MD Anderson on cancer drugs












(Reuters) – GlaxoSmithKline signed a collaboration agreement with the MD Anderson Cancer Center in Houston to develop new drugs that promote a patient’s immune system to attack cancer based on discoveries by Anderson researchers.


Anderson, one of the world’s premier cancer research and treatment centers, announced the agreement on Friday. Under terms of the deal, it will receive an undisclosed upfront payment and research funding from Glaxo and could earn $ 335 million plus royalties if the collaboration leads to approved medicines.












The British drugmaker will get exclusive worldwide rights to develop and sell antibodies that activate OX40, a protein on the surface of T cells – a type of white blood cell that is an important component of the body’s immune system. The antibodies were discovered by Dr. Yong-Jun Liu and colleagues when he was professor and chair of MD Anderson’s Department of Immunology.


“This agreement is … a testament to the vision shared by GSK and MD Anderson that successful clinical development of oncology drugs requires seamless integration of drug development expertise and deep biological knowledge,” Dr Giulio Draetta, director of Anderson’s Institute for Applied Cancer Science, said in a statement.


So-called immunotherapies, which help the body’s immune system to more efficiently attack cancer, are seen as an important new frontier is the fight against the disease in its many forms. Several companies are developing promising cancer immunotherapies.


Any drugs that come out of the Glaxo-Anderson collaboration would be several years away as more preclinical testing is needed before the OX40 approach will be tested in human subjects, MD Anderson said.


(Reporting by Bill Berkrot; Editing by Nick Zieminski)


Medications/Drugs News Headlines – Yahoo! News


Read More..

US jobless rate at four-year low













The US added 146,000 jobs in November, official data shows, as the economy seemingly shrugged off storm Sandy.












The unexpectedly strong performance brought the unemployment rate down to a four-year low of 7.7% of the workforce.


The jobs figure was well above most analysts’ expectations and continued a recent surge that began in July.


Weekly benefits data registered a sharp but short-lived jump in the number claiming unemployment benefits in the states ravaged by the storm last month.


“Our analysis leads us to conclude that Hurricane Sandy did not substantively impact the national employment and unemployment estimates for November,” said John Galvin, acting commissioner at the Bureau of Labour Statistics (BLS), which produced the jobs report.


The jobs survey data for the individual states – which can be used by analysts to determine what effect, if any, the storm had – will not be released until 21 December.


Wobbly confidence


Stock markets gave the figures a cautiously positive response, with both the Dow Jones and S&P 500 indexes rising 0.3% at the start of trading on Wall Street.


European shares, which had been down for the day following a cut in the Bundesbank’s growth forecast for Germany, jumped about 0.5% on the news.


The US Federal Reserve is due to meet next week to decide whether to expand the central bank’s policy of buying up debt from the markets in order to stimulate the recovery.


Continue reading the main story


US government bonds fell slightly in value following the data release, suggesting that markets have lowered the expectations for further intervention by the Fed in light of the strong jobs growth figure.


However, the Fed’s Open Market Committee will also have to weigh the latest consumer confidence survey, also released on Friday, which saw a sharp fall in sentiment in early December.


The University of Michigan’s consumer sentiment index fell to 74.5 from 82.7 the previous month, reaching a level normally associated with recession, although it was still well above the 55 registered at the depth of the 2008 downturn.


The drop in confidence among ordinary Americans may reflect the impasse in Congress in negotiations to avert the “fiscal cliff” of automatic spending cuts and tax rises that kicks in on 1 January.


Consumer sentiment briefly plummeted in 2011 when the US lost its top triple-A after a similar stand-off over the raising of the legal cap on the US federal government’s ability to borrow.


Mixed message


Although the latest jobs report beat expectations, this was in large part because expectations remain very low.


The number of jobs being added by the US economy since the recession ended has been far weaker than during previous economic recoveries, and has scarcely been enough to keep up with the natural growth in the US population.


The total number of people in employment has been stuck at about 58% of the US population since 2009, well down from the 63% level that characterised the boom years of the past decade, as many Americans have retired or given up seeking work.


Moreover, the relatively good news for November was offset by the BLS’s decision to downwardly revise the jobs figures for the preceding two months by a cumulative total of 49,000.


The October figure – which was originally reported just before the elections as 171,000, prompting some Republican supporters to suggest that the numbers had been manipulated – has been cut in the latest estimate to 138,000.


However, the reduction in the October figure was actually entirely due to public sector jobs cuts – mainly at the state and local government level – being 35,000 higher than originally estimated.


“While more work remains to be done, today’s employment report provides further evidence that the US economy is continuing to heal from the wounds inflicted by the worst downturn since the Great Depression,” said Alan Krueger, chairman of the White House Council of Economic Advisors.


Dropping out


The unemployment rate – which fell to 7.7% in November, down from 7.9% in October – has fallen in fits and starts over the past three years, since peaking at 10% in late 2008, but still remains some way short of the 5% level that has accompanied periods of healthy growth in the past two decades.


The total number of unemployed people remained largely unchanged in the latest month at about 12 million, as did the number of people out of work for over half a year, at 4.8 million. The number of people taking part-time jobs because they cannot find full-time work also remained unchanged at 8.2 million.


Statistics suggest that much of the decline in the unemployment rate since 2008 has been due to people dropping out of the workforce, either due to retirement or because they have given up seeking work.


The unemployment figure only includes those actively seeking a job, and once people stop doing so they drop out of the statistics.


The retail sector continued to lead the way in job creation, with professional services and IT also providing large contributions, while the construction sector, food manufacturing and chemicals saw sizeable job losses.


BBC News – Business


Read More..

Toronto mayor to stay in power pending appeal of ouster












TORONTO (Reuters) – Toronto Mayor Rob Ford can stay in power pending an appeal of a conflict of interest ruling that ordered him out of his job as leader of Canada’s biggest city, a court ruled on Wednesday.


Madam Justice Gladys Pardu of the Ontario Divisional Court suspended a previous court ruling that said Ford should be ousted. Ford’s appeal of that ruling is set to be heard on January 7, but a decision on the appeal could take months.












Justice Pardu stressed that if she had not suspended the ruling, Ford would have been out of office by next week. “Significant uncertainty would result and needless expenses may be incurred if a by-election is called,” she said.


If Ford wins his appeal, he will get to keep his job until his term ends at the end of 2014. If he loses, the city council will either appoint a successor or call a special election, in which Ford is likely to run again.


“I can’t wait for the appeal, and I’m going to carry on doing what the people elected me to do,” Ford told reporters at City Hall following the decision.


Ford, a larger-than-life character who took power on a promise to “stop the gravy train” at City Hall, has argued that he did nothing wrong when he voted to overturn an order that he repay money that lobbyists had given to a charity he runs.


Superior Court Justice Charles Hackland disagreed, ruling last week that Ford acted with “willful blindness” in the case, and must leave office by December 10.


Ford was elected mayor in a landslide in 2010, but slashing costs without cutting services proved harder than he expected, and his popularity has fallen steeply.


He grabbed unwelcome headlines for reading while driving on a city expressway, for calling the police when a comedian tried to film part of a popular TV show outside his home, and after reports that city resources were used to help administer the high-school football team he coaches.


The conflict-of-interest drama began in 2010 when Ford, then a city councillor, used government letterhead to solicit donations for the football charity created in his name for underprivileged children.


Toronto’s integrity commissioner ordered Ford to repay the C$ 3,150 ($ 3,173) the charity received from lobbyists and companies that do business with the city.


Ford refused to repay the money, and in February 2012 he took part in a city council debate on the matter and then voted to remove the sanctions against him – despite being warned by the council speaker that voting would break the rules.


He pleaded not guilty in September, stating that he believed there was no conflict of interest as there was no financial benefit for the city. The judge dismissed that argument.


In a rare apology after last week’s court ruling, he said the matter began “because I love to help kids play football”.


Ford faces separate charges in a C$ 6 million libel case about remarks he made about corruption at City Hall, and is being audited for his campaign finances. The penalty in the audit case could also include removal from office.


(Reporting by Claire Sibonney; Editing by Janet Guttsman, Russ Blinch, Nick Zieminski; and Peter Galloway)


Canada News Headlines – Yahoo! News


Read More..

mtvU honors Frank Ocean, wounded Pakistani teen












NEW YORK (AP) — The mtvU network is honoring a rap superstar who detailed his love for another man and a Pakistani girl shot for her education advocacy as its Man and Woman of the Year.


Frank Ocean, who earned six Grammy nominations Wednesday, published a letter online about his first love, a man, just as his “channel ORANGE” disc was being released. MtvU on Thursday called it “an incredibly brave move for an artist on the verge of superstardom.”












Fifteen-year-old Malala Yousufzai (mah-LAH’-lah YOO’-suf-ZAY’) blogged about her support of education for girls in Pakistan. For that, Taliban militants stormed her school bus and shot her in the head and neck, but she survived.


The mtvU network is geared toward college students and is seen on more than 750 campuses.


Entertainment News Headlines – Yahoo! News


Read More..

Vitamin D, calcium disappoint in dementia study












NEW YORK (Reuters Health) – Vitamin D and calcium supplements taken together in low doses offered no protection against dementia in a large U.S. study of older women, but scientists are still holding out hope for vitamin D alone.


Past research has suggested that vitamin D might protect against memory loss and overall functional decline in the aging brain. But more than 2,000 women in the new study who took 400 international units of vitamin D and 1,000 mg of calcium daily for an average of eight years developed cognitive impairments at the same rates as a comparison group on placebo pills.












During the many years that study was ongoing, however, experts gained a better understanding of how calcium and vitamin D might have conflicting effects, so the combination of the two might explain the disappointing results, the study’s authors say.


“I think the definitive study will just look at the effects of vitamin D,” said lead author Dr. Rebecca Rossom, from HealthPartners Institute for Education and Research, a nonprofit arm of a health maintenance organization (HMO) based in Minneapolis.


But this study is important because it “gets closer to how women take vitamin D now,” as a way build bone density, Rossom added.


Her team’s report, which is published in the Journal of the American Geriatrics Society, is also the first to use the rigorous approach known as a randomized, double-blind trial with a placebo group to look at the possible effects of vitamin D and calcium on cognitive decline.


Rossom and her colleagues analyzed data on 4,100 women who were simultaneously enrolled in two trials, including the Women’s Health Initiative (WHI) Calcium and Vitamin D trial that ended in 2005, and a WHI memory study.


All of the women, who averaged 71 years old at the outset of the studies, were also free of cognitive problems to start.


Half of the women were assigned to take the supplements and the rest were given identical looking dummy pills.


Ultimately, about 100 women, or five percent, in each group developed mild cognitive impairment – a term that can include everything from memory trouble to the serious dementia found in Alzheimer’s disease.


The researchers note that since the study ended, guidelines on vitamin and mineral intakes have changed. Currently the U.S. Institute of Medicine suggests getting 600 IUs per day of vitamin D for men and women up to age 70, and 800 IUs for older people. Suggested calcium amounts range from 700 mg to 1,300 mg per day, based on age, with an upper limit of 3000 mg. In both cases, intake recommendations cover both food and supplement sources.


So, the authors point out, their findings are specific only to the assigned amounts of vitamin D and calcium taken by women in the study – which are relatively low by today’s standards.


More than 16 million Americans suffer from some form of cognitive impairment, according to the U.S. Centers for Disease Control and Prevention, and the problem is expected to grow as more baby boomers age. Vitamin D might still be viewed as potentially offering a measure of protection against a condition with no formal treatment, if its effects can be decisively demonstrated.


“The sum of information shows conflicting evidence,” said Katherine Tucker of Northeastern University, who was not involved in the current study.


“Some recent studies suggest that too much calcium could have negative effects. The preponderance of evidence shows that vitamin D is protective, but some studies have shown no effect,” she told Reuters Health.


But, Tucker said, “This study by no means closes the door on the need for more research to clarify vitamin D’s effects.”


Rossom’s team acknowledges their study’s limitations. In addition to the doses of supplements in the trial, the results are strictly limited to women, who were mostly white. Also, older age is a significant risk factor for dementia and the study participants, by comparison, were relatively young.


“The next step is to test a higher dose of vitamin D,” said study coauthor JoAnn Manson of Harvard Medical School. “Higher doses will bring a study population to an achieved blood level that has been associated with reduced risk of cognitive decline in (past) studies.”


Manson is currently leading a large clinical trial designed primarily to look at the effects of vitamin D and omega-3′s on cancer risk, but the study will also monitor cognitive function. Results are expected in 2017.


A French study slated to finish next year is examining the cognitive effects of vitamin D versus a placebo in patients who already have Alzheimer’s disease.


“The bottom line is that we still just don’t know,” Tucker told Reuters Health. “We’re in the process of gathering more scientific evidence and will need to continue to do so until more studies point in a certain direction.”


SOURCE: http://bit.ly/VCIs9H Journal of the American Geriatrics Society, online November 23, 2012.


Health News Headlines – Yahoo! News


Read More..

Freeport downgraded as analysts question shift into energy, stock slips












(Reuters) – Shares of Freeport-McMoRan Copper & Gold Inc fell further on Thursday, a day after it said it had struck deals to expand into energy by acquiring Plains Exploration & Production Co and McMoRan Exploration Co for $ 9 billion, and at least four analysts downgraded the miner’s stock.


The transactions, valued at $ 19.6 billion including debt, were lambasted by investors and analysts alike as being unnecessary and a distraction from Freeport‘s copper business.












Freeport shares fell 5 percent to a 15-month low of $ 30.58 in morning trade before recovering slightly. The stock fell 15 percent on Wednesday after the announcement of the deals.


The investor backlash was exacerbated by the disclosure after the announcement that shareholders won’t be allowed to vote on the deal, meaning the only way they have to express their dissatisfaction is to dump the stock.


“We believe that Freeport stock will remain in the penalty box for the foreseeable future and multiples will remain depressed on the back of these acquisition announcements, given investor uncertainty on the strategic merit,” analysts at Goldman Sachs wrote in a research note.


The move into oil and gas means the company will lose its status as a pure-play copper and gold miner, analysts said.


“Freeport’s diversification into oil and gas arguably removes a key investment draw of the company in its copper exposure,” BMO Capital Markets analysts wrote.


Evy Hambro, a managing director at BlackRock, one of Freeport’s top-five shareholders, condemned the deal on Wednesday, saying there was no reason why the three companies should be put together.


Plains shares, which rose 23.4 percent on Wednesday, were down 2.2 percent at $ 43.48 while McMoRan Exploration‘s shares, which had risen 87 percent, were down 3.4 percent at $ 15.27.


The deal’s high debt component was also viewed as negative.


Standard & Poor’s cut its rating outlook on Freeport to negative from stable, including the company’s BBB corporate credit rating. “The negative outlook on Freeport reflects the leveraged nature of the proposed acquisitions, as well as risks associated with integrating the targeted companies,” S&P said.


The cost of protecting debt issued by Freeport against potential default fell slightly after rising sharply on Wednesday immediately after the deal announcement.


Five-year credit default swaps were 1.5 basis points tighter at 153 basis points. That means it costs $ 153,000 a year to protect $ 10 million of debt for five years. The CDS widened about 12 percent on Wednesday.


Yield spreads on the company’s 3.55 percent bonds due March, 2022 widened another 4 basis points to 206 basis points over 10-year Treasuries.


INVESTOR CONCERNS


Freeport said on Wednesday that the rationale for entering into the deal was to use low-cost financing available to the company to make attractive investments.


But analysts including Citigroup’s Brian Yu said there was no or little strategic fit or rationale for the deal.


Yu said he expected the deal to dilute Freeport’s 2013 earnings per share by 3.2 percent.


The Goldman Sachs analysts said Freeport would have to address investor concerns about the valuations of the deal, considering cross-ownership and management links among the three companies.


Both Freeport-McMoRan Copper & Gold and the company now known as McMoRan Exploration Co were spun off in the 1980s and 1990s from the former Freeport-McMoRan Inc.


Jim Bob Moffett is chairman of Freeport-McMoRan and co-chairman and chief executive of McMoRan Exploration. In addition, Plains owns nearly one-third of McMoRan Exploration’s shares after a 2010 asset sale.


Some analysts said the $ 6.9 billion deal for Plains undervalued the company, while $ 2.1 billion for McMoRan was on the high end.


“If the high risk ultra-deep drilling does not work, Freeport greatly overpaid for McMoRan in our view,” analysts at RBC Capital Markets said.


McMoRan has struggled with delays at its Davy Jones deep gas prospect off Louisiana.


Analysts at Nomura said the high debt load made a special dividend less likely and eroded any takeover premium in Freeport’s stock.


Nomura cut its price target on Freeport’s stock to $ 36 from $ 40, while UBS decreased its target $ 40 from $ 47.


Freeport shares were down 3.9 percent at $ 30.91 in early afternoon trading on the New York Stock Exchange.


(Reporting by Swetha Gopinath in Bangalore; Editing by Ted Kerr)


Business News Headlines – Yahoo! News


Read More..

Death toll from Philippine typhoon nears 300












NEW BATAAN, Philippines (AP) — Stunned parents searching for missing children examined a row of mud-stained bodies covered with banana leaves while survivors dried their soaked belongings on roadsides Wednesday, a day after a powerful typhoon killed nearly 300 people in the southern Philippines.


Officials fear more bodies may be found as rescuers reach hard-hit areas that were isolated by landslides, floods and downed communications.












At least 151 people died in the worst-hit province of Compostela Valley when Typhoon Bopha lashed the region Tuesday, including 78 villagers and soldiers who perished in a flash flood that swamped two emergency shelters and a military camp, provincial spokeswoman Fe Maestre said.


Disaster-response agencies reported 284 dead in the region and 14 fatalities elsewhere from the typhoon, one of the strongest to hit the country this year.


About 80 people survived the deluge in New Bataan with injuries, and Interior Secretary Mar Roxas, who visited the town, said 319 others remained missing.


“These were whole families among the registered missing,” Roxas told the ABS-CBN TV network. “Entire families may have been washed away.”


The farming town of 45,000 people was a muddy wasteland of collapsed houses and coconut and banana trees felled by Bopha’s ferocious winds.


Bodies of victims were laid on the ground for viewing by people searching for missing relatives. Some were badly mangled after being dragged by raging flood waters over rocks and other debris. A man sprayed insecticide on the remains to keep away swarms of flies.


A father wept when he found the body of his child after lifting a plastic cover. A mother, meanwhile, went away in tears, unable to find her missing children. “I have three children,” she said repeatedly, flashing three fingers before a TV cameraman.


Two men carried the mud-caked body of an unidentified girl that was covered with coconut leaves on a makeshift stretcher made from a blanket and wooden poles.


Dionisia Requinto, 43, felt lucky to have survived with her husband and their eight children after swirling flood waters surrounded their home. She said they escaped and made their way up a hill to safety, bracing themselves against boulders and fallen trees as they climbed.


“The water rose so fast,” she told AP. “It was horrible. I thought it was going to be our end.”


In nearby Davao Oriental, the coastal province first struck by the typhoon as it blew from the Pacific Ocean, at least 115 people perished, mostly in three towns that were so battered that it was hard to find any buildings with roofs remaining, provincial officer Freddie Bendulo and other officials said.


“We had a problem where to take the evacuees. All the evacuation centers have lost their roofs,” Davao Oriental Gov. Corazon Malanyaon said.


The International Federation of Red Cross and Red Crescent Societies issued an urgent appeal for $ 4.8 million to help people directly affected by the typhoon.


The sun was shining brightly for most of the day Wednesday, prompting residents to lay their soaked clothes, books and other belongings out on roadsides to dry and revealing the extent of the damage to farmland. Thousands of banana trees in one Compostela Valley plantation were toppled by the wind, the young bananas still wrapped in blue plastic covers.


But as night fell, however, rain started pouring again over New Bataan, triggering panic among some residents who feared a repeat of the previous day’s flash floods. Some carried whatever belongings they could as they hurried to nearby towns or higher ground.


After slamming into Davao Oriental and Compostela Valley, Bopha roared quickly across the southern Mindanao and central regions, knocking out power in two entire provinces, triggering landslides and leaving houses and plantations damaged. More than 170,000 fled to evacuation centers.


As of Wednesday evening, the typhoon was over the South China Sea west of Palawan province. It was blowing northwestward and could be headed to Vietnam or southern China, according to government forecasters.


The deaths came despite efforts by President Benigno Aquino III’s government to force residents out of high-risk communities as the typhoon approached.


Some 20 typhoons and storms lash the northern and central Philippines each year, but they rarely hit the vast southern Mindanao region where sprawling export banana plantations have been planted over the decades because it seldom experiences strong winds that could blow down the trees.


A rare storm in the south last December killed more than 1,200 people and left many more homeless.


The United States extended its condolences and offered to help its Asian ally deal with the typhoon’s devastation. It praised government efforts to minimize the deaths and damage.


___


Associated Press writers Jim Gomez, Teresa Cerojano and Oliver Teves in Manila contributed to this report.


Asia News Headlines – Yahoo! News


Read More..

Jazz pianist Dave Brubeck dead at 91












NEW YORK (Reuters) – Jazz pianist Dave Brubeck, whose choice of novel rhythms, classical structures and brilliant sidemen made him a towering figure in modern jazz, has died at the age of 91, his longtime manager and producer Russell Gloyd said on Wednesday.


Brubeck died of heart failure on Wednesday morning after he fell ill on his way to a regular medical exam at Norwalk Hospital, in Norwalk, Conn., a day short of his 92nd birthday, Gloyd said.












His Dave Brubeck Quartet put out one of the best selling jazz songs of all time: “Take Five,” composed by alto saxophonist Paul Desmond. Like many of the group’s works, it had an unusual beat — 5/4 time as opposed to the usual 4/4.


“We play it differently every time we play it,” Brubeck told The Philadelphia Inquirer in 2005. “So I never get tired of playing it. That’s the beauty of jazz.”


“Take Five” was the first million-selling jazz single.


Dressed in a suit and horn-rimmed glasses and living a clean-cut lifestyle in the 1950s, Brubeck did not fit the stereotype of a hipster jazzman and his music was not nearly as brooding as that coming from East Coast be-bop players.


Despite his innovative approach, some critics interpreted Brubeck’s popularity as a sign of un-coolness, but his fans were undeterred.


Brubeck was born in Concord, California, on December 6, 1920. His father was a rancher and as a teenager Brubeck was a skilled cowboy. But his mother, a music teacher who had five pianos in the house, saw that he took up piano at age 5.


At the College of the Pacific in Stockton, California, he planned to be a veterinarian, but within a year he was majoring in music and playing jazz in nightclubs.


“After my first year in veterinary pre-med I switched to the music department … and that was at the advice of my zoology teacher,” Brubeck said in a Reuters interview. “He said ‘Brubeck, your mind is not here, with these frogs and formaldehyde. Your mind is across the lawn at the conservatory. Will you please go over there.’”


Brubeck later met the co-director of a weekly campus radio show, Iola Marie Whitlock, and they eventually married.


After graduation, Brubeck studied under French composer Darius Milhaud and played in a U.S. Army jazz band during World War Two.


In the late 1940s, he moved to the San Francisco Bay area, where he headed an experimental jazz octet. He formed a trio in 1950 and the following year expanded to a quartet with Desmond, who he had known since the war.


Brubeck injected classical counterpoint, atonal harmonies and modern dissonance into his music, hinting at composers such as Debussy, Bartok, Stravinsky and Bach.


The group built an enduring fan base by taking its subdued bluesy brand of classically influenced jazz to colleges.


As a leading figure in the West Coast jazz scene, which also included Gerry Mulligan and Chet Baker, Brubeck was featured in a Time magazine cover story in 1954. Some critics and black musicians, who felt jazz was a central part of black culture, resented the story about the prominence of a white artist.


In the article Brubeck said Milhaud had told him “if I didn’t stick to jazz, I’d be working out of my own field and not taking advantage of my American heritage.”


Brubeck disbanded the quartet in 1967 after nearly 17 years to concentrate on composing. He wrote several choral works, all religiously influenced.


He later began performing jazz regularly again and appeared with his sons, Darius, a composer and pianist; Chris, who played electric bass and trombone; and drummer Danny. They were billed as Two Generations of Brubeck.


In February 1989 Brubeck, who had a history of heart problems, underwent triple-bypass surgery but kept playing. Well into his 80s, he still put on some 80 shows a year. He had a pacemaker implanted in October 2010.


Actor-director Clint Eastwood, a jazz fan, announced plans to make a documentary on Brubeck in 2007. Eastwood also was named chairman of the Brubeck Institute at the University of the Pacific, designated as the home of his papers, private recordings and other memorabilia.


Brubeck and his wife, who also was his agent and lyricist, had two other sons, Matthew, a cellist, and Michael, and a daughter, Catherine. The couple lived in Wilton, Connecticut.


(Reporting by Christine Kearney; Editing by Leslie Gevirtz)


Celebrity News Headlines – Yahoo! News


Read More..

With Teva at crossroads, new CEO set to unveil vision












NEW YORK/TEL AVIV (Reuters) – Teva Pharmaceutical Industries‘ new Chief Executive Jeremy Levin has promised investors it will be a very different company going forward. Next week he has to prove it.


Levin’s ability to paint a bright future for the world’s biggest maker of generic drugs at a meeting with investors and analysts on December 11 in New York became a bit more difficult last week, when Teva issued a 2013 earnings forecast that fell short of Wall Street estimates.












Levin, a big pharma veteran, is expected to shift Teva’s focus to branded drugs even as its most important such product, top-selling multiple sclerosis treatment Copaxone, faces new competition and a 2015 patent expiration. Investors are also hoping for a meaningful boost to the annual dividend while new management works to jumpstart a stagnant share performance.


“I’ve made a lot of money in Teva and I’ve seen this company wither in front of my eyes,” said Dan Hunt, a co-portfolio manager for RCM Capital Management’s Wellness Fund. Hunt’s fund no longer includes Teva shares, but RCM has small Teva holdings.


“The most important signal (shareholders) need to hear on the record from Levin is ‘whatever it takes I will protect you’,” Hunt said, adding that Teva has not delivered for its shareholders in years.


Teva’s U.S. shares are up about 2 percent in 2012 after falling 22.6 percent in 2011. They are off 35 percent from a 2010 peak at about $ 64. Shareholders of smaller Teva rivals Watson Pharmaceuticals Inc and Mylan Inc have fared far better with Watson up about 45 percent this year and Mylan shares up about 27 percent over the same period.


Levin has taken some preemptive steps to placate investors ahead of the meeting by announcing that the company plans to cut $ 1.5 billion to $ 2 billion in costs over the next five years, streamline operations and discontinue some research programs.


Morgan Stanley estimated that Copaxone sales account for 58 percent of Teva’s projected 2013 earnings. Levin will have to reveal how he plans to make up for the anticipated decline in Copaxone revenue beyond cost-cutting efforts.


Generic drugs accounted for 56 percent of Teva’s revenue last year, but the company faces obstacles to generic growth in the United States, the world’s largest market.


Following a wave of major patent expirations, the number of multibillion-dollar drugs going generic will diminish after the next couple of years. And new generic drugs are facing competition sooner along with faster price declines. Generic drugs are also facing considerable price pressure in Europe.


SMALL ACQUISITIONS


South African-born Levin, a former senior vice president for strategy at Bristol-Myers Squibb Co, took over as CEO of Israel’s biggest company in May, replacing Shlomo Yanai.


In five years at the helm, Yanai engineered a number of large acquisitions, including last year’s $ 6.5 billion purchase of U.S. drugmaker Cephalon, which has been viewed by some analysts as a disappointment. The company last month took a $ 481 million impairment charge related to the Cephalon deal.


Levin last week signaled a desire for more targeted acquisitions focused on Teva’s core areas of expertise, such as central nervous system disorders and respiratory diseases.


He has begun to whittle away at non-core businesses, selling Teva’s U.S. animal health unit to Bayer for up to $ 145 million. Investors said Teva needs to improve production efficiency and downsize or close some of its plants.


Levin, who implemented at Bristol-Myers a series of deals and alliances with small and large companies, has been credited with helping to guide Bristol through its enormous patent cliff as the blood clot preventer Plavix, which had been the world’s second biggest selling prescription medicine, lost exclusivity.


“The key is smart deals and getting an estimate of what a reasonable growth rate is going forward,” said Robert Caravella, equity research analyst for Victory Capital Management, which holds about $ 9 million in Teva convertible bonds.


“The biggest issue is there’s not an understanding of where revenue and earnings are going to go and how we’re going to get to that point,” he said.


BIGGER DIVIDEND?


Shareholders would also like to see Teva raise its dividend, which provides only a 2.5 percent return on the stock, below the industry average of about 4 percent. Alternatively, the company may decide to increase shareholder returns by boosting its $ 3 billion share buyback.


Steven Tepper, an analyst at brokerage Harel Finance, said Levin must demonstrate how Teva can again become a growth company or that it will be a value investment going forward through a significant dividend increase. “This plan will have to convince investors it’s making that move,” Tepper said.


RCM Capital’s Hunt said Levin must present “a strong, formed, clear strategic vision” of where the company is headed.


The question is whether it will be enough to convince disenchanted investors such as Stewart Capital, which has more than $ 1 billion in assets under management but sold its Teva holdings shortly after Levin took over.


Matthew DiFilippo, chief portfolio strategist for Stewart, was skeptical that one individual could effect the change necessary to transform Teva back into an industry darling. “So while we recognized his talents, we also recognized the challenges they face and we sold,” he said.


A lot of money remains on the sidelines waiting for what Levin has to say, said Ori Hershkovitz, managing partner at Israel-based pharmaceutical hedge fund Sphera. Levin needs to say he is committed to replenishing Teva’s branded pipeline and will do whatever it takes to replace those lost sales by 2016, Hershkovitz said, and he must “make the market believe it”.


(Additional reporting by Steven Scheer in Jerusalem; Editing by Leslie Gevirtz)


Medications/Drugs News Headlines – Yahoo! News


Read More..

Citigroup in 11,000 staff cull













Citigroup says it is cutting 11,000 jobs worldwide in an efficiency drive, with most of the jobs being lost in its consumer banking division.












The bank said the move, which will see its headcount shrink by 4%, would cost it about $ 1bn (£621m) in pre-tax charges.


Shares in the bank rose 7% following the announcement.


The move comes two months after the bank’s former chief executive, Vikram Pandit, suddenly resigned.


Michael Corbat took over from Mr Pandit as chief executive.


The bank said the $ 1bn charge would be recorded in its fourth-quarter figures for this year.


It said it would also add another $ 100m in charges to the first half profits for 2013.


Citigroup said the changes would leave it $ 900m better off in 2013 and a further $ 1.1bn the following year.


The company said that about 25% of the charges for the fourth quarter related to its securities and banking division, with another 10% in transaction services.


Another third would come from reductions in its global consumer banking division, where 6,200 positions would be cut.


Moving out


The banking group said it would be selling or scaling back consumer operations in Pakistan, Paraguay, Romania, Turkey and Uruguay.


Other countries affected by the changes would be Brazil, Hong Kong, Hungary, South Korea and the US.


It is also closing branches in Greece and Spain, countries hard-hit by the eurozone crisis.


It intends to focus on the 150 cities that have the highest growth potential in consumer banking.


After the changes, Citi said it would have more than 4,000 retail branches around the world.


At the time of Mr Pandit’s sudden departure, the bank’s chairman, Michael O’Neill, said the departure was not due to any “strategic, regulatory or operating issue”.


Mr Pandit left the bank with a settlement of more than $ 15m.


He resigned a day after Citi reported an 88% drop in quarterly profits to $ 468m.


BBC News – Business


Read More..

WestJet embraces tech to woo business travelers












TORONTO (Reuters) – WestJet Airlines Ltd will use technological innovation, including a new Internet ticket booking system, to help it transform from a no-frills carrier to a lower-cost full-service airline courting lucrative corporate travelers, its chief executive said on Monday.


Canada’s second-biggest airline plans to launch a series of technology systems, most notably the new online booking engine, which will sell three tiers of tickets, in the next two months.












“Companies evolve or they die,” Chief Executive Gregg Saretsky told Reuters in a phone interview from the company’s Calgary head office.


“We’re 16 and going on 17 years old and we can’t stay just as we were 17 years ago. The world has changed. And we are changing to be more relevant for a broader segment of guests.”


The new Internet booking system, which WestJet hopes to launch in late January, will sell economy, mid-tier and premium tickets. That is a major shift from its current system, which sells only the lowest-priced ticket available.


Economy tickets under the new system will continue to sell the lowest available fare, but the cancellation fee for them will jump to C$ 75 ($ 75.48) from C$ 50. Mid-tier tickets will have a C$ 50 cancellation fee.


Premium tickets, unavailable until late March when WestJet finishes reconfiguring its 100 Boeing 737 planes to allow more leg room, will include priority screening and boarding, free cancellations and flexibility on ticket changes.


Pricing for those tickets, which may include free meals and drinks and an extra baggage allowance, has not yet been determined. Fares will be well below half the price for business class at WestJet’s bigger competitor, Air Canada, Saretsky said.


“It’s time for us to be more serious with respect to going after business travelers because frankly, they’re the ones who are booking last-minute and are happy to pay for the conveniences,” Saretsky said.


WestJet will launch its premium economy service with 24 seats per plane, but will consider expansion if it proves “wildly successful,” he added.


POISED FOR CHANGE


WestJet, which has spent about C$ 40 million over the past two years on technology projects, is poised for major changes in 2013 as it readies to launch a new regional airline, Encore.


Saretsky hopes that WestJet’s switch in coming weeks to a new Internet phone system will allow ticket reservation agents to work from home and help make room for Encore staff.


Some 750 reservation agents work at WestJet’s Calgary offices, which house about 2,400 staff. Space will be needed for Encore employees over the next 18 months while their office, hangars and maintenance stores are constructed at the WestJet campus.


Encore will be launch in the second half of 2013, “probably closer to July than December,” Saretsky said, with seven Bombardier Q400 planes.


While WestJet won’t announce Encore’s schedule until Jan 21, the carrier will initially serve only “a handful” of new cities, with ticket prices up to 50 percent below Air Canada’s, he added.


Over the next two months, WestJet will also roll out a guest notification system that alerts travelers via email about their flights, allowing them to check in remotely.


Such self-service technology will be critical as WestJet faces increasing labor costs, Saretsky said.


Wage and benefit costs, which represent about a third of operating costs, have climbed 50 percent since WestJet was founded in 1996.


“You can see that creates a little bit of drag on earnings,” Saretsky said. “We’ve got to find ways of reducing our component costs.”


If WestJet can increase self service options for travelers, that could limit the need for new employees, Saretsky said. Management also wants to improve attendance management, so that fewer employees book off sick around long weekends, and more quickly clean and process planes between flights, he said.


(Reporting By Susan Taylor; Editing by Peter Galloway)


(This story was corrected to show that WestJet is replacing its Internet booking engine, not entire reservation system, in the first and second paragraphs)


Canada News Headlines – Yahoo! News


Read More..

Longtime editor at DC’s Vertigo imprint leaving












PHILADELPHIA (AP) — DC Entertainment says its executive editor and senior vice president of Vertigo — a groundbreaking imprint whose titles have included “Hellblazer,” ”DMZ” and “Sandman” — is leaving early next year.


Karen Berger will step down in March after nearly 20 years at the helm, saying in a statement released by DC late Monday that she is ready for a professional change.












During her tenure at Vertigo, the imprint saw a wide range of writers and artists — Neil Gaiman, Jill Thompson, Becky Cloonan and Brian Wood, among them — who produced titles beyond the traditional superhero and villain archetype.


Gerard Way of My Chemical Romance and writer of “The Umbrella Academy” tweeted that Berger gave “us weird kids in high school a Sub Pop Records for comics.”


___


Online:


http://www.vertigocomics.com


Entertainment News Headlines – Yahoo! News


Read More..

After parent’s cancer death, one in five kids self-injure












NEW YORK (Reuters Health) – One in five teens who lost one of their parents to cancer cut or burn themselves, compared to one in ten teens with two living parents, according to a new Swedish study.


“We were very surprised to find that so many did it,” said lead researcher Tove Grenklo, a behavioral scientist at the Karolinska Institutet in Stockholm.












Cutting and burning is thought to be how some troubled teens express their emotions, according to the American Academy of Child and Adolescent Psychiatry. Those teens may hurt themselves if they can’t talk about their feelings, are upset or have low self esteem.


Earlier this year, a study found that children start harming themselves as early as third grade. (see Reuters Health article of June 11, 2012. http://reut.rs/Kveo8v)


The study’s researchers write in the Archives of Pediatrics and Adolescent Medicine that past research showed children with one dead parent are already more likely to have – among other things – psychiatric problems, depression, drug and alcohol abuse and anxiety.


Grenklo and her colleagues wanted to see if they were also more likely to hurt themselves.


For the study, they used Sweden’s national death databases to find and survey teens who lost one of their parents to cancer between 2000 and 2003, when they were between 13 and 16.


They then found teens who still had two living parents for a comparison group.


Of the 851 teens who lost a parent, 622 returned their survey, as did 330 of the 451 teens in the comparison group.


Overall, about 20 percent of the teens with only one surviving parent said they hurt themselves, compared to about 10 percent of teens with both parents living.


‘WE SHOULD TALK WITH EACH OTHER’


“This study is one of the first to establish that (losing a parent to cancer) might be a unique risk factor for this behavior,” said Stephen Lewis, who was not involved with the new study but has studied self-injury at the University of Guelph in Ontario, Canada.


Lewis added that the study’s findings seem to be in line with other estimates of how many teens injure themselves.


The researchers say teens may be driven to self-injure after their parents’ deaths by an increased sense of emotional distress and numbness.


Another possible explanation for the increase is that the teens lost a caretaker who would notice their emotional suffering and prevent self-injury, they add.


As for prevention, both Grenklo and Lewis emphasized communication.


“I’m a strong believer that we should talk with each other,” said Grenklo. “Children need to know the facts of what happened and why. And that it’s OK to be sad and talk about the diseased parent.”


“We know one of the reasons people self injure is that they use injuring as a way to release their emotions,” said Lewis, who added that it’s important for parents, family members and teachers to know how to talk about self-injury and how to prevent it.


Lewis said information on preventing and handling self injury can be found at SIOutreach.org – a Web site where he is co-director.


SOURCE: http://bit.ly/TLILN8 Archives of Pediatrics and Adolescent Medicine, online December 3, 2012.


Parenting/Kids News Headlines – Yahoo! News


Read More..

Insight: UK court reveals fear and mistrust at TNK-BP












LONDON (Reuters) – A former TNK-BP employee may have confessed to fraud out of fear during a meeting in the office of German Khan, the head of the oil company and one of Russia’s most prominent businessmen, according to a British High Court judge.


In the first judicial account of encounters earlier this year between Khan and his former subordinate Igor Lazurenko, testimonies from the two men paint a picture of fear and mistrust at TNK-BP, one of the country’s largest private companies which is half-owned by Britain’s BP.












The actions and methods of Khan and other oligarchs who grew rich from the privatizations of the 1990s are a sensitive issue in Russia, where President Vladimir Putin is trying to increase state control and crack down on profiteering without scaring off investment. The case opens a window on a world where courts, police and imprisonment are seen by many Russians as tools of the wealthy.


Khan, BP and TNK-BP’s other shareholders are trying to fold their business into state oil company Rosneft. Closing the deal, one of the biggest energy takeovers in history, would net them billions of dollars in cash and could make them shareholders in the state company.


BP has secured government approval to acquire Rosneft shares from the state and expects to complete its part of the sale by mid-2013, but Khan’s side of the deal is only partly formed and has no approvals yet. The whole deal is worth $ 55 billion.


“Whilst it is clearly not possible at this stage to make any definitive findings… Mr. Khan’s own evidence provides some support for Mr. Lazurenko‘s evidence that he was coerced into making this confession,” said Andrew Sutcliffe QC, sitting as judge of London’s High Court, in a November 20 decision.


This week, TNK-BP decided not to appeal the judgment, and on Tuesday, Lazurenko’s lawyers were seeking a total of 1.6 million pounds ($ 2.6 million) in costs from the company.


In his 88-page ruling, Sutcliffe dismissed TNK-BP’s attempts to bring fraud charges against Lazurenko, a one-time Russian army officer who was in charge of organizing oil transport contracts. Sutcliffe called TNK-BP’s potential for a case “very weak”, described some claims as “false and misleading” and was critical about its lack of evidence against Lazurenko.


TNK-BP has also abandoned its attempts to stop Lazurenko from publishing certain documents in his possession. Lazurenko has said they provide evidence of high-level corporate and government corruption and implicate high ranking Russian officials. He has not published them.


The claimant in the November 20 ruling is OJSC TNK-BP Holding, the main holding company of TNK-BP. The defendants are Lazurenko, three other individuals, and a number of companies with which he is connected.


TNK-BP alleged that Lazurenko, who worked for the company from 2003 until he quit this year, took bribes and laundered the money through businesses operating in Montenegro. In August, TNK-BP obtained a UK court order that froze 39 million euros ($ 51 million) worth of the defendants’ assets.


The judge’s account in the November 20 ruling reveals a detailed picture of the encounters in Khan’s office.


In one of them, Lazurenko’s testimony says, Khan told him he stood accused of accepting $ 8 million in bribes for oil transport contracts and threatened “strong action” against him and his family if he did not admit to doing so. Lazurenko denied the allegations on that occasion.


As he arrived for a later meeting, Lazurenko says he saw a man sitting outside “who looked to me like he was from the Moscow police or Ministry of Internal Affairs. I find it hard to explain in the English court how and why I formed this impression,” he said, “but I think it would be very obvious to a Russian judge. It relates to the way this individual looked and was dressed.”


Inside, “Khan told me he had someone outside his office who would arrest me unless I admitted that I had received this money and agreed to repay it”.


He said Khan also told him to remember the fate of Viktor Paliy, a business associate of AAR, through which Khan holds his stake in TNK-BP, who ended up in prison.


“I was scared and knew that I could not continue to deny his allegations if I wanted to get out of his office and leave the building. Therefore I admitted the allegation, even though I knew it to be untrue,” the court document cited Lazurenko saying.


Khan, in his testimony, acknowledged that he referred to the implications for Lazurenko’s family, and that he mentioned the fate of Paliy. He said his intention was to persuade Lazurenko to admit to his crimes.


BETTER TO CONFESS


“I may well have said that if he did not make an admission it would cause serious problems for him. I did not say that he had to confess if he wanted to get out of my office freely and leave the building,” said Khan in his testimony.


Khan denied there had been a policeman outside the office, but said “there may have been someone from internal security service, many of whom are former law enforcement officers.”


He went on to say Lazurenko had “a reputation as a very cold, detached individual”, and that any suggestion he was frightened was “wholly ridiculous.”


However, Sutcliffe used more of Khan’s own testimony to back up his judicial view that Lazurenko might have been right to be scared.


“I told Mr. Lazurenko on at least one occasion that he should think about his family,” the judge quoted Khan as saying. “This was not a threat to harm either Mr. Lazurenko or any members of his family … It is a well-known fact that persons accused of economic crimes can spend years in prison even before being tried, and risk having their assets frozen by the state pending trial… I was offering Mr. Lazurenko a sensible alternative. Pay back the money he stole from TNK-BP and thus avoid the risk of prison.”


The judge also noted Khan’s response to Lazurenko’s description of him as “extremely ruthless”.


“As is well known,” Khan said, “Doing business in Russia is not for the faint hearted.”


Asked for a response to the judgment and the judge’s remarks, TNK-BP said in an emailed statement it was “confident in our position and will continue pursuing Mr. Lazurenko in all appropriate jurisdictions.”


It added: “Before fleeing Russia Mr. Lazurenko admitted his wrongdoing against the company… Mr. Lazurenko did not make any reports to the Russian or English police about any coercion.”


A spokesman for Lazurenko said: “The two damning judgments against TNK-BP… bring to an end a seven month campaign instigated by TNK-BP in an attempt to gag Mr Lazurenko and guarantee his silence.


“Despite its vast resources and lengthy investigations, TNK-BP has been unable to produce any evidence to support its allegations against Mr Lazurenko,” he said in an email.


BP and AAR, a consortium holding 50 percent of TNK-BP, both declined to comment on the contents of the court document.


GAGGING ORDER


The separate UK gagging order keeping Lazurenko’s documents secret was lifted on October 16. The judge who lifted it revealed that Transneft, the Russian pipelines monopoly, was named in the corruption allegations. Transneft has declined to comment on the subject. TNK-BP had plans to appeal against the lifting of the injunction, but has since dropped that action too.


The Khan-Lazurenko dispute dates back to March when Khan made Lazurenko the subject of an internal inquiry. In April, Lazurenko resigned and left Russia.


TNK-BP is a 50-50 venture between BP and AAR. AAR is a consortium owned by Khan and fellow tycoons Mikhail Fridman, Viktor Vekselberg and Len Blavatnik.


BP has been at odds with the AAR shareholders on and off for years. Problems came to a head in 2010 when BP wanted to do business with increasingly powerful Rosneft, and the tycoons resisted. The sale to Rosneft is set to bring the saga to an end.


BP last month won Russian government approval to acquire Rosneft shares from the state holding company Rosneftegaz, a step on the way to securing $ 12.3 billion of cash and an 18.5 percent stake in Rosneft that will raise its holding to 19.75 percent. AAR’s side of the deal is less complete, but Rosneft has said it hopes to agree it in December.


After the acquisition, Rosneft, headed by Putin ally Igor Sechin, will be pumping 4.6 million barrels of oil equivalent, more than U.S.-based Exxon Mobil.


Lazurenko was represented by solicitors Mischon de Reya and TNK-BP by Bryan Cave.


(additional reporting by Doug Busvine in Moscow and Dmitry Zhdannikov in London; editing by Janet McBride)


Business News Headlines – Yahoo! News


Read More..

Official: Syria moving chemical weapons components












WASHINGTON (AP) — U.S. and allied intelligence have detected Syrian movement of chemical weapons components in recent days, a senior U.S. defense official said Monday, as the Obama administration strongly warned the Assad regime against using them.


A senior defense official said intelligence officials have detected activity around more than one of Syria‘s chemical weapons sites in the last week. The defense official spoke on condition of anonymity because he was not authorized to speak publicly about intelligence matters.












Secretary of State Hillary Rodham Clinton, in Prague for meetings with Czech officials, reiterated President Barack Obama‘s declaration that Syrian action on chemical weapons was a “red line” for the United States that would prompt action.


“We have made our views very clear: This is a red line for the United States,” Clinton told reporters. “I’m not going to telegraph in any specifics what we would do in the event of credible evidence that the Assad regime has resorted to using chemical weapons against their own people. But suffice it to say, we are certainly planning to take action if that eventuality were to occur.”


Syria said Monday it would not use chemical weapons against its own people. The Ministry of Foreign Affairs said Syria “would not use chemical weapons — if there are any — against its own people under any circumstances.”


Syria has been careful never to confirm that it has any chemical weapons.


The use of chemical weapons would be a major escalation in Assad’s crackdown on his foes and would draw international condemnation. In addition to causing mass deaths and horrific injuries to survivors, the regime’s willingness to use them would alarm much of the region, particularly neighboring states, including Israel.


At the White House, press secretary Jay Carney said, “We are concerned that in an increasingly beleaguered regime, having found its escalation of violence through conventional means inadequate, might be considering the use of chemical weapons against the Syrian people. And as the president has said, any use or proliferation of chemical weapons by the Syrian regime would cross a red line for the United States. “


Administration officials would not detail what that response might be.


Although Syria is one of only seven nations that have not signed the Chemical Weapons Treaty, it is a party to the 1925 Geneva Protocol that bans the use of chemical weapons in war. That treaty was signed in the aftermath of World War I, when the effects of the use of mustard gas and other chemical agents outraged much of the world.


Clinton didn’t address the issue of the fresh activity at Syrian chemical weapons depots, but insisted that Washington would address any threat that arises.


An administration official said the trigger for U.S. action of some kind is the use of chemical weapons or movement with the intent to use or provide them to a terrorist group like Hezbollah. The U.S. is trying to determine whether the recent movement detected in Syria falls into any of those categories, the official said. The administration official was speaking on condition of anonymity this person was not authorized to speak publicly about the issue.


The senior defense official said the U.S. does not believe that any Syrian action beyond the movement of components is imminent.


An Israeli official said if there is real movement on chemical weapons, it would require a response. He didn’t say what that might be and spoke on condition of anonymity pending a formal government response to the reports of the latest activities.


Israeli officials have repeatedly expressed concerns that Syrian chemical weapons could slip into the hands of Hezbollah or other anti-Israel groups, or even be fired toward Israel in an act of desperation by Syria.


Syria is believed to have several hundred ballistic surface-to-surface missiles capable of carrying chemical warheads.


Its arsenal is a particular threat to the American allies, Turkey and Israel, and Obama singled out the threat posed by the unconventional weapons earlier this year as a potential cause for deeper U.S. involvement in Syria’s civil war. Up to now, the United States has opposed military intervention or providing arms support to Syria’s rebels for fear of further militarizing a conflict that activists say has killed more than 40,000 people since March 2011.


Clinton said that while the actions of President Bashar Assad‘s government have been deplorable, chemical weapons would bring them to a new level.


“We once again issue a very strong warning to the Assad regime that their behavior is reprehensible, their actions against their own people have been tragic,” she said. “But there is no doubt that there’s a line between even the horrors that they’ve already inflicted on the Syrian people and moving to what would be an internationally condemned step of utilizing their chemical weapons.”


Activity has been detected before at Syrian weapons sites, believed to number several dozen.


Defense Secretary Leon Panetta said in late September the intelligence suggested the Syrian government had moved some of its chemical weapons in order to protect them. He said the U.S. believed that the main sites remained secure.


Asked Monday if they were still considered secure, Pentagon press secretary George Little declined to comment about any intelligence related to the weapons.


Senior lawmakers were notified last week that U.S. intelligence agencies had detected activity related to Syria’s chemical and biological weapons, said a U.S. intelligence official, speaking on condition of anonymity to discuss the closed-door meetings. All congressional committees with an interest in Syria, from the intelligence to the armed services committees, are now being kept informed.


“I can’t comment on these reports but I have been very concerned for some time now about Syria’s stockpiles of chemical weapons and its stocks of advanced conventional weapons like shoulder-launched anti-aircraft missiles,” said House intelligence committee Chairman Mike Rogers, R-Mich. “We are not doing enough to prepare for the collapse of the Assad regime, and the dangerous vacuum it will create. Use of chemical weapons by the Assad regime would be an extremely serious escalation that would demand decisive action from the rest of the world,” he added.


Syria is believed to have one of the world’s largest chemical weapons programs, and the Assad regime has said it might use the weapons against external threats, though not against Syrians. The U.S. and Jordan share the same concern about Syria’s chemical and biological weapons — that they could fall into the wrong hands should the regime in Syria collapse and lose control of them.


___


Klapper reported from Prague. Associated Press writers Josef Federman in Jerusalem, Albert Aji in Damascus and Matthew Lee, Kimberly Dozier, and Julie Pace in Washington contributed to this report.


Europe News Headlines – Yahoo! News


Read More..